Clinical Trials
16 trialsNCT04309552 2026-01-27
Tumor Hypoxia and Proliferation in Patients With High-Grade Glioma
Weill Medical College of Cornell University
Phase 1 Suspended
NCT02016872 2025-04-30
Prognostic Value of Tumor Hypoxia, as Measured by 18F-FMISO Breath Hold PET/CT, in Non-Small-Cell-Lung Cancer (NSCLC) Patients
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT03649880 2025-03-25
Feasibility of FMISO in Brain Tumors
OHSU Knight Cancer Institute
Phase 2 Recruiting
NCT05250895 2025-03-13
BOLD MRI and FMISO PET for the Assessment of Hypoxic Tumor Microenvironment in Patients with Oligometastatic Liver Cancer Undergoing Yttirum-90 Selective Internal Radiation Therapy
Emory University
Phase EARLY_PHASE1 Completed
NCT06087614 2025-01-17
DE-HyART
Rajiv Gandhi Cancer Institute & Research Center, India
Phase 2 Recruiting
NCT01246869 2024-10-01
Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water
University of Utah
Phase 1 Terminated
NCT05996432 2024-09-23
Image-Based, In-Vivo Assessment of Tumor Hypoxia to Guide Hypoxia-Driven Adaptive Radiation Therapy
Vanderbilt-Ingram Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT02695628 2024-01-31
[18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver Cancer
Stanford University
Phase 2 Completed
NCT00606294 2023-06-28
Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography To Detect Hypoxia in Head and Neck Cancer Patients
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT01967927 2021-08-19
Understanding GRID Radiation Therapy Effects on Human Tumor Oxygenation and Interstitial Pressure to Increase Translation of Solid Tumor Therapy
University of Arkansas
Phase EARLY_PHASE1 Withdrawn
NCT03730077 2021-03-18
FMISO PET/CT Imaging Trial for Assessing Hypoxia in Soft Tissue Sarcomas
University of Pennsylvania
Phase 1 Terminated
NCT03303469 2021-02-21
Hypoxic Changes in Hepatocellular Carcinoma (HCC) Following Trans Arterial Chemo Embolization and Stereotactic Radiation: Fluorine18 (18F) Fluoromisonidazole (FMISO) Imaging
University of Alabama at Birmingham
Phase 2 Terminated
NCT03573986 2020-02-17
Pilot Study of 18F-FMISO PET/CT and MRI Imaging to Explore Tissue Hypoxia and Arteriovenous Shunting in Subjects With Recurrent Glioblastoma Before and After Bevacizumab Treatment
Abramson Cancer Center at Penn Medicine
Phase 1 Terminated
NCT01868906 2018-08-24
FMISOPETSCS
Dr. Negrin University Hospital
Phase 2 Terminated
NCT02061007 2016-05-09
Biomarker Correlates of Hypoxia in Metastatic Melanoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Withdrawn
NCT00038038 2012-08-01
Assessment of Head and Neck Tumor Hypoxia Using 18F-Fluoromisonidazole
M.D. Anderson Cancer Center
Phase NA Withdrawn